🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
The aim of this trial is to evaluate the efficacy and safety of 2.5 and 5 m...
Status
Completed
Location
205.419.01058 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01172821
This study will investigate whether study subjects with previously uncontro...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-07-26
Trial ID
NCT00351143
This study will assess the efficacy, tolerability and safety of NVA237 comp...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01513460
Treatments Being Tested
The purpose of the trial was to evaluate the efficacy and safety of two dif...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-12-08
Trial ID
NCT02571777
Treatments Being Tested
This study will evaluate the onset of action of indacaterol (150 and 300 µg...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-04
Trial ID
NCT00669617
To confirm the robustness of the CRC749 inhaler....
Status
Completed
Location
Mylan Investigational Site
Start Date
2015-05
Trial ID
NCT02474017
Treatments Being Tested
The primary objective of the study was to demonstrate the superiority of Fo...
Status
Completed
Location
Aarhus University Hospital
Start Date
2011-04-12
Trial ID
NCT01245569
Treatments Being Tested
This study evaluated the safety and efficacy of 26 weeks treatment with ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-11
Trial ID
NCT00567996
Treatments Being Tested